Philips’ VISIQ device has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Touted as the breakthrough ultrasound device, the transducer-plus-tablet can be easily transported wherever care is needed. The VISIQ also has a quick-start technology and long battery life that make it an ideal system for physician offices, hospitals and other clinical settings.
VISIQ offers many of the automatic image optimization features found on Philips’ premium EPIQ system.“VISIQ marks a new vision in ultrasound for Philips by allowing physicians to perform on-the-spot diagnostic scans, limiting the need for patients to go to multiple locations or schedule return visits,” said Gene Saragnese, CEO, Imaging Systems, Philips Healthcare. “VISIQ is the latest example of Philips’ continued commitment to create advanced innovative technology solutions to deliver better care at lower cost and to help improve patient outcomes.”
Not only does VISIQ allows users to easily capture images, take measurements and share data; it also offers many of the automatic image optimization features found on Philips’ premium EPIQ system.
Aside from the U.S. where it will be available soon, the device is also available in China, East Africa, France, Germany and India.